Home » Newsletters » BioWorld Science

BioWorld Science

July 23, 2015

View Archived Issues

Prevention of HIV transcription from latency by Tat inhibitor

BioRestorative Therapies to evaluate encapsulation technology for use in metabolic program

Dauntless Pharmaceuticals closes series A financing, licenses technology from Aegis

KalVista Pharmaceuticals raises funds to advance plasma kallikrein inhibitor pipeline

Merck & Co.'s Keytruda approved in Europe for advanced melanoma

Novartis presents milestones of second quarter 2015

Discovery and optimization of a pan-RET/VEGFR-2 dual inhibitor for single-agent polypharmacology

New organotypic brain slice culture model helps elucidate Alzheimer's disease pathology

Horizon Pharma increases share offer for Depomed

CNGA2 KO mice show AD-like pathological features

Beaufour Ipsen Tianjin Pharmaceutical describes AR degraders

Intra-Cellular Therapies plans phase III program for ITI-007 in bipolar depression

Polyphor reports selective elastase inhibitors

Catalyst initiates rolling NDA for Firdapse in LEMS

West China Hospital, Sichuan University reports short-acting anesthesic

Novartis files sBLA for ofatumumab as maintenance therapy for relapsed CLL

Alectos Therapeutics designs GCase inhibitors

Erum Biotechnologies patents PTP-1B inhibitors

Vidasym's phosphate binder VS-505 enters phase I/II trial

Phase I study investigates T4 immunotherapy for head and neck cancer

Xoma reports data from phase III EYEGUARD-B study

Roche Diagnostics launches HTLV blood test

AMAG Pharmaceuticals obtains option to acquire digoxin immune fab for pre-eclampsia

NIH funds collaborative project to develop measures of social impairment in autism

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 15, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 16, 2025.
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...
CTAD 2025: The challenges of combination therapies for dementia
BioWorld Science
At the Clinical Trials on Alzheimer’s Disease 2025 meeting, a panel of experts discussed the need for developing combination therapies for the complex diseases...